Skip to main content
. Author manuscript; available in PMC: 2015 Mar 1.
Published in final edited form as: J Cancer Res Clin Oncol. 2014 Jan 18;140(3):443–452. doi: 10.1007/s00432-014-1583-9

Figure 3. In vitro combination data evaluating DCA and cisplatin under hypoxic conditions.

Figure 3

The sensitivity of four cell lines, HCC-827 (A), SKLU-1 (B), A549 (C) and A427 (D), were evaluated by exposing cells to decreasing concentrations of DCA starting at 10 mM and cisplatin starting at 2 M. Error bars indicate the standard error based on multiple experiments.